{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-082266","form_type":"8-K","ticker":"ACXP","cik":"0001736243","company_name":"Acurx Pharmaceuticals, Inc.","filed_at":"2022-07-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.858762+00:00","generated_at":"2026-06-24T09:15:29.166572+00:00","sec_items":["1.01","2.02","3.02","5.05","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Acurx Pharmaceuticals raises $4.225M in registered direct offering; reports $9.1M cash","bullets":["Gross proceeds of ~$4.225M from sale of 1,289,980 shares/pre-funded warrants at $3.25 (institutional) and $3.80 (executives).","Concurrent private placement of Series A and B warrants to purchase up to 1,289,980 shares each; exercisable starting 6 months.","Preliminary cash and equivalents $9.1M as of June 30, 2022 (unaudited).","Board granted one-time waiver of Insider Trading Policy to let CEO, Executive Chairman, and director participate in the offering.","Net proceeds for general corporate purposes; closing expected July 27, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-082266","json":"https://secwatch.observer/filing/0001104659-22-082266.json","markdown":"https://secwatch.observer/filing/0001104659-22-082266.md","text":"https://secwatch.observer/filing/0001104659-22-082266.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1736243/000110465922082266/0001104659-22-082266-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1736243/000110465922082266/tm2221625d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T09:15:29.166572+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}